Unilife enters into an exclusivity agreement with Amgen in effect through the end of the month during which they will negotiable a license deal for Unilife's wearable injector devices. In consideration of the exclusive period, Amgen has paid the company a non-refundable deposit of $15M.
Why would Amgen pay $15M for nothing? It's not a rhetorical question, its more of opening up topics for discussion on the deal.
UNS Price at posting:
21.5¢ Sentiment: None Disclosure: Held